Galderma’s Ready-to-Use, Extended-Duration Formula and Botulinum Toxin Type E Herald a New Chapter in Customizable Tox Procedures
PHOENIX, AZ, UNITED STATES, October 2, 2026 /EINPresswire.com/ — PHOENIX, AZ — Dr. Rebecca Weiss, DO, a board-certified physician and the medical director at Paradise Medspa, is offering patients and colleagues an early glimpse into two novel neuromodulator therapies currently navigating the FDA approval pathway—advancements she believes could alter the landscape of how aesthetic specialists approach wrinkle-relaxing treatments in the coming years.
This update was shared during the latest episode of Dr. Weiss’s “Thirsty Thursday With Dr. Weiss,” an informal, educational video series in which she discusses the newest trends in aesthetic medicine live from the Paradise Medspa location in Phoenix, Arizona.
A Quick-Onset, Brief-Duration Choice: Bont E
The initial product, designated Bont E (Botulinum toxin type E), comes from the creators of Botox and marks a shift away from the Botulinum toxin type A formulations currently prevalent in the industry. Dr. Weiss explains that Bont E cleaves the SNAP-25 protein at a distinct site compared to type A toxins, leading to visible aesthetic outcomes within 8–24 hours—far faster than existing products.
It is crucial to note that the drawback of Bont E lies in its longevity: effects are projected to persist for roughly two weeks only. Dr. Weiss indicates this profile might position Bont E as a prime candidate for:
Minor refinements between complete treatment sessions
Individuals seeking rapid-onset outcomes
First-time toxin patients desiring a low-commitment “trial run” prior to opting for more durable treatments
A Pre-Diluted, Extended-Release Formula: Relfydess
The second product, identified in earlier reports as Relfydess, is under development by Galderma, the manufacturer of Dysport. In contrast to conventional freeze-dried toxins that necessitate reconstitution, Relfydess is set to be supplied pre-mixed in a solution—a production innovation that Dr. Weiss highlights could enhance uniformity across different practices and clinicians.
Clinical evidence referenced by Dr. Weiss during the episode indicates Relfydess begins working within a few days and could potentially produce effects lasting up to six months for certain patients, establishing it as a viable extended-duration substitute for current options such as Daxxify.
Both Treatments Pending FDA Approval
Dr. Weiss observed that both companies have received FDA requests for supplementary information prior to market entry, a typical step in the regulatory process. She projects that these products might launch as soon as 2027, contingent on final authorization.
“I think I’m not concerned really about the safety of either of these two products,” said Dr. Weiss. “I do think that there was a reason the FDA was asking for additional information just related to the manufacturing process… once they can prove that they’ve gone through all of those checks and balances, then hopefully this product is going to be released to market.”
Reevaluating Dilution Techniques
Dr. Weiss additionally used the segment to tackle a rising discussion among injectors regarding the preparation of neuromodulators. Although numerous practices utilize bacteriostatic saline to enhance patient comfort during dilution, she pointed to findings from a recent industry talk indicating that normal saline—the standard employed in initial clinical trials—might more effectively maintain product effectiveness, with some estimates suggesting a potential 20% discrepancy. She notes that Paradise Medspa intends to delve deeper into this topic via internal comparative testing.
About Paradise Medspa
Established in 2008, Paradise Medspa is a premier medical spa in Phoenix, Arizona, delivering a comprehensive array of cosmetic, wellness, and skincare services. Under the leadership of Dr. Rebecca Weiss, DO — a board-certified Family Physician and a prominent figure in cosmetic injectables — alongside Dr. Kristine Sarna, MD, the clinic has assisted numerous clients in reaching their aesthetic and wellness objectives via customized, science-backed care.
For additional details or to schedule a visit, check out paradisemedspa.com or connect with Paradise Medspa on Instagram, TikTok, Facebook, and YouTube
Media Contact:
Charlie Queeno
cqueeno@paradisemedspa.com
Paradise Medspa
Phoenix, Arizona
paradisemedspa.com
Charlie Queeno
Paradise Medspa
+1 602-266-8144
email us here
